Sheets Smith Investment Management »

Iovance Biotherapeutics shares owned by Sheets Smith Investment Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Sheets Smith Investment Management from 13F filings

Historical chart of Sheets Smith Investment Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Sheets Smith Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Sheets Smith Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $44k 20k 2.17

More positions owned by Sheets Smith Investment Management

J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Applovin Corp Com Cl A (APP)
Putnam Master Inter Income T Sh Ben Int (PIM)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Amazon (AMZN)
Howmet Aerospace (HWM)
Palantir Technologies Cl A (PLTR)
New Gold Inc Cda (NGD)
Bank of America Corporation (BAC)
Microsoft Corporation (MSFT)
Citigroup Com New (C)
Advanced Micro Devices (AMD)
Pan American Silver Corp Can (PAAS)

View all positions for Sheets Smith Investment Management

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics